| 51 |
17390065 | The growth inhibition of liver cancer cells by paclitaxel and the involvement of extracellular signal-regulated kinase and apoptosis. | 2007 May |
11 |
| 52 |
16051289 | Enhancement of esculetin on Taxol-induced apoptosis in human hepatoma HepG2 cells. | 2006 Jan 1 |
1 |
| 53 |
16395709 | p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis. | 2006 Jun 15 |
2 |
| 54 |
16397234 | Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt. | 2006 Jan 1 |
3 |
| 55 |
16515784 | ERK activation by thymosin-beta-4 (TB4) overexpression induces paclitaxel-resistance. | 2006 May 15 |
4 |
| 56 |
16721826 | Different signaling responses to anti-proliferative agents in human aortic and venous smooth muscle cells. | 2006 Oct 15 |
2 |
| 57 |
16969513 | Paclitaxel and ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells. | 2006 Oct |
4 |
| 58 |
15592521 | A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway. | 2005 Jan 27 |
1 |
| 59 |
15657900 | Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity. | 2005 May 20 |
2 |
| 60 |
15778245 | MAP kinases in lung endothelial permeability induced by microtubule disassembly. | 2005 Jul |
2 |
| 61 |
15805287 | Enhancement of the therapeutic efficacy of taxol by the mitogen-activated protein kinase kinase inhibitor CI-1040 in nude mice bearing human heterotransplants. | 2005 Apr 1 |
1 |
| 62 |
15870880 | Modulation of Raf/MEK/ERK kinase activity does not affect the chemoresistance profile of advanced prostate cancer cells. | 2005 Jun |
1 |
| 63 |
16101130 | Biomarkers of anticancer activity of R115777 (Tipifarnib, Zarnestra) in human breast cancer models in vitro. | 2005 Sep-Oct |
2 |
| 64 |
16211241 | Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death. | 2005 Nov |
5 |
| 65 |
15241487 | MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol. | 2004 Jul 8 |
1 |
| 66 |
12691824 | Down-regulation of Raf-1 kinase is associated with paclitaxel resistance in human breast cancer MCF-7/Adr cells. | 2003 Apr 10 |
2 |
| 67 |
12087097 | Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel. | 2002 Sep 6 |
3 |
| 68 |
12121974 | Gamma-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways. | 2002 Sep 20 |
1 |
| 69 |
12181740 | Variable apoptotic response of NSCLC cells to inhibition of the MEK/ERK pathway by small molecules or dominant negative mutants. | 2002 Sep |
1 |
| 70 |
11170175 | Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells. | 2001 Feb 1 |
2 |
| 71 |
11245462 | Inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells. | 2001 Feb 15 |
1 |
| 72 |
11278851 | Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery. | 2001 Jun 1 |
4 |
| 73 |
11313944 | Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. | 2001 Jan 11 |
4 |
| 74 |
11455016 | Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines. | 2001 Aug |
6 |
| 75 |
11461121 | The role of ERK 1/2 and p38 MAP-kinase pathways in taxol-induced apoptosis in human ovarian carcinoma cells. | 2001 Aug 1 |
6 |
| 76 |
11720482 | Differential effect of vinorelbine versus paclitaxel on ERK2 kinase activity during apoptosis in MCF-7 cells. | 2001 Nov 2 |
5 |
| 77 |
10623471 | Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells. | 2000 Jan 10 |
2 |
| 78 |
11038347 | MEK inhibition enhances paclitaxel-induced tumor apoptosis. | 2000 Dec 15 |
2 |
| 79 |
9927194 | Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells. | 1999 Jan 14 |
1 |
| 80 |
10097113 | Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. | 1999 Mar 30 |
1 |
| 81 |
9443400 | Transient stimulation of the c-Jun-NH2-terminal kinase/activator protein 1 pathway and inhibition of extracellular signal-regulated kinase are early effects in paclitaxel-mediated apoptosis in human B lymphoblasts. | 1998 Jan 15 |
3 |
| 82 |
9774447 | Paclitaxel (Taxol)-induced gene expression and cell death are both mediated by the activation of c-Jun NH2-terminal kinase (JNK/SAPK). | 1998 Oct 23 |
2 |